Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients
- PMID: 35559039
- PMCID: PMC9086273
- DOI: 10.3389/fgene.2022.868942
Description of the Molecular and Phenotypic Spectrum of Lesch-Nyhan Disease in Eight Chinese Patients
Abstract
Background: Lesch-Nyhan disease (LND) is a rare disorder involving pathogenic variants in the HPRT1 gene encoding the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) that result in hyperuricemia, intellectual disability, dystonic movement disorder, and compulsive self-mutilation. The purpose of the present study was to characterize the genetic basis of LND and describe its phenotypic heterogeneity by identifying the variation in the HPRT1 gene in a cohort of Chinese LND patients. Results: The median age at diagnosis was 31 mo (interquartile range (IQR): 7-76 mo), and the initial manifestations were mainly head control weakness and motor development delay. The median age of self-mutilation behavior onset was 19 mo (IQR: 17-24 mo), and all patients were required to travel in a wheelchair and fall into the predicament of compulsive self-harm behavior. There were two patients whose blood uric acid levels were normal for their high urinary acid excretion fraction without taking uric acid-lowering drugs. Seven different pathogenic variants of the HPRT1 gene were identified among eight independent pedigrees, including four novel mutations [c.299 (exon 3) T > A; loss (exon: 6) 84 bp; c.277_281delATTGC; c.468_470delGAT]. The pathogenic variant sites were mainly concentrated in exon 3, and truncating mutations (including frameshift mutations and nonsense mutations) were the most common genetic variant types (5/7, 71.4%). Conclusion: The present study described the phenotypic and molecular spectrum of LND in eight Chinese families, including four novel mutations, which expands our understanding of LND.
Keywords: HPRT1 gene; Lesch-Nyhan disease; dystonia; hyperuricemia; self-mutilation.
Copyright © 2022 Li, Qiao, Liu, Wang, Shen, Fu and Mao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Phenotypic and molecular spectrum of Korean patients with Lesch-Nyhan syndrome and attenuated clinical variants.Metab Brain Dis. 2019 Oct;34(5):1335-1340. doi: 10.1007/s11011-019-00441-0. Epub 2019 May 25. Metab Brain Dis. 2019. PMID: 31129767
-
HPRT1 Disorders.2000 Sep 25 [updated 2020 Aug 6]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2000 Sep 25 [updated 2020 Aug 6]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301328 Free Books & Documents. Review.
-
Potential molecular link between the β-amyloid precursor protein (APP) and hypoxanthine-guanine phosphoribosyltransferase (HGprt) enzyme in Lesch-Nyhan disease and cancer.AIMS Neurosci. 2021 Oct 28;8(4):548-557. doi: 10.3934/Neuroscience.2021030. eCollection 2021. AIMS Neurosci. 2021. PMID: 34877405 Free PMC article. Review.
-
Human HPRT1 gene and the Lesch-Nyhan disease: Substitution of alanine for glycine and inversely in the HGprt enzyme protein.Nucleosides Nucleotides Nucleic Acids. 2017 Feb;36(2):151-157. doi: 10.1080/15257770.2016.1231319. Epub 2017 Jan 3. Nucleosides Nucleotides Nucleic Acids. 2017. PMID: 28045594
-
Mild Lesch-Nyhan Disease in a Boy with a Null Mutation in HPRT1: An Exception to the Known Genotype-Phenotype Correlation.JIMD Rep. 2015;18:135-7. doi: 10.1007/8904_2014_368. Epub 2014 Nov 4. JIMD Rep. 2015. PMID: 25366392 Free PMC article.
Cited by
-
Detailed genetic and clinical analysis of a novel de novo variant in HPRT1: Case report of a female patient from Saudi Arabia with Lesch-Nyhan syndrome.Front Genet. 2023 Jan 26;13:1044936. doi: 10.3389/fgene.2022.1044936. eCollection 2022. Front Genet. 2023. PMID: 36778911 Free PMC article.
-
Case report: Early-onset renal failure as presenting sign of Lesch-Nyhan disease in infancy.Front Pediatr. 2022 Dec 19;10:1080486. doi: 10.3389/fped.2022.1080486. eCollection 2022. Front Pediatr. 2022. PMID: 36601030 Free PMC article.
-
Case report: Whole exome sequencing identifies a novel variant in the HPRT1 gene in a male with developmental delay.Front Genet. 2025 Feb 28;16:1512070. doi: 10.3389/fgene.2025.1512070. eCollection 2025. Front Genet. 2025. PMID: 40092560 Free PMC article.
-
Susceptibility genes of hyperuricemia and gout.Hereditas. 2022 Aug 4;159(1):30. doi: 10.1186/s41065-022-00243-y. Hereditas. 2022. PMID: 35922835 Free PMC article. Review.
-
Lesch-Nyhan Syndrome and Oral Self-injury: A Systematic Review of Case Reports.Int J Clin Pediatr Dent. 2024 Dec;17(12):1431-1438. doi: 10.5005/jp-journals-10005-2990. Int J Clin Pediatr Dent. 2024. PMID: 39867109 Free PMC article. Review.
References
-
- Bertelli M., Randi D., Micheli V., Gallo S., Andrighetto G., Parmigiani P., et al. (2004). Molecular Basis of Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Italian Lesch-Nyhan Patients: Identification of Nine Novel Mutations. J. Inherit. Metab. Dis. 27 (6), 767–773. 10.1023/B:BOLI.0000045799.78633.23 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous